RBCC: Survey Shows Teen Substance Abuse Falling, But Much Work Remains

Rainbow Coral Corp. (OTCQB: RBCC) is hailing a recent nationwide survey that shows substance abuse and addiction among American teens has dropped, but the company says a lot of hard work still lies ahead before the current crisis can be considered over.

According to the recently released Monitoring the Future (MTF) survey, young people have decreased their use of many addictive substances, including prescription opioid painkillers, alcohol, cigarettes and synthetic cannabinoids (also known as synthetic marijuana). Use of prescription opioids has sunk to its lowest level in 12 years, with 4.4 percent of high school seniors reporting non-medical use, down from a 10.5 percent in 2003.

“This is heartening news,” said RBCC CEO Kimberly Palmer. “It shows the continued effort against opioid and alcohol addiction is having a measurable and positive effect among teens. However, a lot of work remains ahead and more needs to be done across all age groups. The addiction crisis hasn’t gone away, despite this encouraging survey. This is why we are heavily focused on that segment still battling alcohol and opioid addiction – the adult population. And that’s why we are continuing our work towards developing affordable treatment options for those in need.”

The MTF survey, conducted annually by the University of Michigan, measures drug use and attitudes among U.S. eighth, 10th, and 12th graders.

Through its biotech subsidiary, Rainbow Biosciences, RBCC markets and develops new medical and research technology innovations to compete alongside companies such as Biogen Idec Inc. (BIIB), Abbott Laboratories (ABT) and Amgen Inc. (AMGN).

For more information on RBCC’s initiatives, please visit www.rainbowbiosciences.com.

About Rainbow Biosciences

Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit www.RainbowBioSciences.com. For investment information and performance data on the Company, please visit www.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160128005795/en/